Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NASDAQ:GRTS

Gritstone Oncology (GRTS)

2.46
-0.00 (0.00%)
as of May 2, 2023, 6:16:46 pm Market Open.
0 watching
0
COMMENT
A biotech that's up 342% in the past week, because yesterday they announced they're working on a 2nd-generation Covid vaccine. They already an agreement with the National Institute for Allergy and Infectious Diseases to start testing it. Their immunotherapy-based vaccine could be a game-changer even in phase 1 testing.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Gritstone Oncology (GRTS) Frequently Asked Questions

What is Gritstone Oncology stock symbol?

Gritstone Oncology is a American stock, trading under the symbol GRTS (previously GRTS-Q on Stockchase) on the NASDAQ (GRTS). It is usually referred to as NASDAQ:GRTS or GRTS

Is Gritstone Oncology a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on GRTS (previously GRTS-Q on Stockchase) on Stockchase. Read the latest expert commentary for Gritstone Oncology.

Is Gritstone Oncology a good investment or a top pick?

Gritstone Oncology was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Gritstone Oncology.

Why is Gritstone Oncology stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Gritstone Oncology.

Is Gritstone Oncology worth watching?

Gritstone Oncology is covered by Stockchase experts and is worth watching.

What is Gritstone Oncology stock price?

On 2023-05-02, Gritstone Oncology (GRTS) stock closed at a price of $2.46.